These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37053460)

  • 1. Rational Engineering Docetaxel Prodrug Nanoassemblies: Response Modules Guiding Efficacy Enhancement and Toxicity Reduction.
    Wang D; Li L; Xu H; Sun Y; Li W; Liu T; Li Y; Shi X; He Z; Zhai Y; Sun B; Sun J
    Nano Lett; 2023 Apr; 23(8):3549-3557. PubMed ID: 37053460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minor Changes in Response Modules Leading to a "U-Shaped" Conversion Rate of Docetaxel Prodrug Nanoassemblies.
    Li W; Wang D; Zhao H; Xu H; Li L; Huang Y; Shi X; Sun J; He Z; Sun B
    Nano Lett; 2024 Jan; 24(1):394-401. PubMed ID: 38147432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the Role of Connecting Bonds and Modifying Chains in the Rational Design of Prodrug Nanoassemblies.
    Wang D; Du C; Wang S; Li L; Liu T; Song J; He Z; Zhai Y; Sun B; Sun J
    ACS Appl Mater Interfaces; 2022 Nov; 14(45):51200-51211. PubMed ID: 36397309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big Responsibilities.
    Zuo S; Sun B; Yang Y; Zhou S; Zhang Y; Guo M; Sun M; Luo C; He Z; Sun J
    Small; 2020 Nov; 16(45):e2005039. PubMed ID: 33078579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel.
    Li Y; Chen X; Ji J; Li L; Zhai G
    Carbohydr Polym; 2021 Mar; 255():117393. PubMed ID: 33436222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy.
    Zhang S; Guan J; Sun M; Zhang D; Zhang H; Sun B; Guo W; Lin B; Wang Y; He Z; Luo C; Sun J
    Drug Deliv; 2017 Nov; 24(1):1460-1469. PubMed ID: 28950729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassemblies.
    Li L; Zuo S; Dong F; Liu T; Gao Y; Yang Y; Wang X; Sun J; Sun B; He Z
    Asian J Pharm Sci; 2021 May; 16(3):337-349. PubMed ID: 34276822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction-Responsive Docetaxel Prodrug Encapsulated within Human Serum Albumin Nanoparticles for Cancer Therapy.
    Zhang Y; Zhang H; Wang J; Liu C; Xing H; Jiang Y; Li X
    Mol Pharm; 2023 May; 20(5):2513-2526. PubMed ID: 37071030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of lengths of branched-chain fatty alcohols on the efficacy and safety of docetaxel-prodrug nanoassemblies.
    Wang S; Liu T; Huang Y; Du C; Wang D; Wang X; Lv Q; He Z; Zhai Y; Sun B; Sun J
    Acta Pharm Sin B; 2024 Mar; 14(3):1400-1411. PubMed ID: 38486988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precise engineering of disulfide bond-bridged prodrug nanoassemblies to balance antitumor efficacy and safety.
    Sun Y; Wang S; Li Y; Wang D; Zhang Y; Zhang H; Lei H; Liu X; Sun J; Sun B; He Z
    Acta Biomater; 2023 Feb; 157():417-427. PubMed ID: 36513247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy.
    Sun B; Luo C; Zhang X; Guo M; Sun M; Yu H; Chen Q; Yang W; Wang M; Zuo S; Chen P; Kan Q; Zhang H; Wang Y; He Z; Sun J
    Nat Commun; 2019 Jul; 10(1):3211. PubMed ID: 31324811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precisely albumin-hitchhiking tumor cell-activated reduction/oxidation-responsive docetaxel prodrugs for the hyperselective treatment of breast cancer.
    Wei W; Luo C; Yang J; Sun B; Zhao D; Liu Y; Wang Y; Yang W; Kan Q; Sun J; He Z
    J Control Release; 2018 Sep; 285():187-199. PubMed ID: 30017721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel prodrug self-assembled nanosystem: Synthesis, formulation and cytotoxicity.
    Jing F; Guo Q; Xu W; Qu H; Sui Z
    Bioorg Med Chem Lett; 2018 Feb; 28(4):826-830. PubMed ID: 29395972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
    Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
    Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the Impact of Surface Functionalization Module on the Performance of Mitoxantrone Prodrug Nanoassemblies: Improving the Effectiveness and Safety.
    Zhang B; Li L; Huang M; Zhao E; Li Y; Sun J; He Z; Fu C; Liu G; Sun B
    Nano Lett; 2024 Mar; 24(12):3759-3767. PubMed ID: 38478977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulating a single thioether-bridged oleate prodrug into a self-nanoemulsifying drug delivery system to facilitate oral absorption of docetaxel.
    Cui W; Zhang S; Zhao H; Luo C; Sun B; Li Z; Sun M; Ye Q; Sun J; He Z
    Biomater Sci; 2019 Feb; 7(3):1117-1131. PubMed ID: 30638237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.
    Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J
    Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
    Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
    Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-sensitive prodrug nanoassemblies based on linoleic acid-modified docetaxel to resist breast cancers.
    Li M; Zhao L; Zhang T; Shu Y; He Z; Ma Y; Liu D; Wang Y
    Acta Pharm Sin B; 2019 Mar; 9(2):421-432. PubMed ID: 30972286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.